AnsinelliRadOnc's profile picture. Father, Husband, Radiation Oncologist at @AZOncology, Tucson AZ. Views my own.

Hayden Ansinelli

@AnsinelliRadOnc

Father, Husband, Radiation Oncologist at @AZOncology, Tucson AZ. Views my own.

Hayden Ansinelli 님이 재게시함

A key to not have burnout is to be at a great program where people are appreciated, heard, and can be change agents.


Hayden Ansinelli 님이 재게시함

#ASTRO25 Getting ready for ARRO/ASTRO/ABS resident workshop. For HDR prostate start w anterior needles and work posterior to avoid shadowing that can impact placement. Also, ABS prostate school coming up with more tips! americanbrachytherapy.org/meetings-event… @AmericanBrachy @ARRO_org

KamravaMD's tweet image. #ASTRO25 Getting ready for ARRO/ASTRO/ABS resident workshop.  For HDR prostate start w anterior needles and work posterior to avoid shadowing that can impact placement. 
Also, ABS prostate school coming up with more tips! 
americanbrachytherapy.org/meetings-event…
@AmericanBrachy @ARRO_org

Hayden Ansinelli 님이 재게시함

Congratulations to my dear colleague @ArjitB_medphys on receiving the @MethodistHosp I CARE award. Not only is he a #medphys #brachytherapy guru. He’s an all around great human being and patient advocate. Great to see him recognized! #bteam

AndrewFarach's tweet image. Congratulations to my dear colleague @ArjitB_medphys on receiving the @MethodistHosp I CARE award. Not only is he a #medphys #brachytherapy guru. He’s an all around great human being and patient advocate. Great to see him recognized! 

#bteam

Hayden Ansinelli 님이 재게시함

Huge surprise at resident graduation ceremony this past week to have received this! Humbled and honored. For me, the highlight of academic medicine is the opportunity/privilege to teach! ⁦Glad to see the residents don’t mind working with me 🙃 ⁦@OhioStateRadOnc⁩ ⁦

Raj_Singh_MD's tweet image. Huge surprise at resident graduation ceremony this past week to have received this! Humbled and honored.  For me, the highlight of academic medicine is the opportunity/privilege to teach! ⁦Glad to see the residents don’t mind working with me 🙃 ⁦@OhioStateRadOnc⁩ ⁦

Hayden Ansinelli 님이 재게시함

First hybrid brachytherapy in Guatemala @AmericanBrachy @KamravaMD @AndrewKellerMD @DocGlaser

Sushilberiwal's tweet image. First hybrid brachytherapy in Guatemala @AmericanBrachy @KamravaMD @AndrewKellerMD @DocGlaser
Sushilberiwal's tweet image. First hybrid brachytherapy in Guatemala @AmericanBrachy @KamravaMD @AndrewKellerMD @DocGlaser

Hayden Ansinelli 님이 재게시함

Hey @BCBSM can you explain to me why you won’t approve prostate SBRT in a patient with intermediate risk prostate cancer? And then I come to find out you want a 3D comparison if I want to use IMRT? You clearly don’t care about the wellbeing of the patient. Despicable…


Hayden Ansinelli 님이 재게시함

🚨 We’re hiring not one but TWO medical oncologists in Parkersburg, WV, a welcoming community with real need, a big heart, and a team that’s ready to support you. A chance to truly make a difference in a community of need: wvumedicine.wd1.myworkdayjobs.com/UHA/job/Camden…

jryckman3's tweet image. 🚨 We’re hiring not one but TWO medical oncologists in Parkersburg, WV, a welcoming community with real need, a big heart, and a team that’s ready to support you. A chance to truly make a difference in a community of need:
wvumedicine.wd1.myworkdayjobs.com/UHA/job/Camden…

Hayden Ansinelli 님이 재게시함

🚀 Ready to elevate your expertise? Register now for #ABSBrachy25 & join key thought leaders in Nashville! Don't miss the chance to connect, learn, and innovate in the field of #brachytherapy.🏙️ #Brachytherapy bit.ly/4iCD1ae @andrewfarach @marisakollmeier @KamravaMD


Hayden Ansinelli 님이 재게시함

Just ask Bob 🎨, #brachytherapy is the ultimate in dose painting A great tx option for nodular #prostatecancer fossa recurrences in upfront & reRT settings. Allows for OAR sparing and dose escalation. #300in10 fellow collab sciencedirect.com/science/articl… #pcsm #radonc

HDR brachytherapy salvage for nodular prostate fossa recurrence: A mechanistic review and initial report of clinical outcomes brachyjournal.com/article/S1538-… this comes up but limited data nice small series @AndrewFarach Also, UCSF PMID: 36623988 and Europe series PMID: 37425206



Hayden Ansinelli 님이 재게시함

Great to catch up with fellow ⁦@MUSOMWV⁩ ‘18 grad and #RadOnc@AnsinelliRadOnc⁩ while in AZ! Go Herd!

Raj_Singh_MD's tweet image. Great to catch up with fellow ⁦@MUSOMWV⁩ ‘18 grad and #RadOnc ⁦@AnsinelliRadOnc⁩ while in AZ! Go Herd!

Hayden Ansinelli 님이 재게시함

For anyone interested in the #300in10 mini-fellowship to develop expertise in #brachytherapy this is a must listen! 👂 Thanks to @MAgarwalMD1 and @KrcRebecca for highlighting the work of the @HMethodistMD #Bteam! Now 12 training sites in the 🇺🇸&🇨🇦 americanbrachytherapy.org/resources/fell…

Don't miss out on #BrachyBites Episode 12! Join @MAgarwalMD1 and @KrcRebecca as they dive into the transformative #ABS300in10 2-month fellowship program focusing on advancing #brachy. bit.ly/4a0Lf8Z #ThisIsBrachytherapy #brachytherapy

AmericanBrachy's tweet image. Don't miss out on #BrachyBites Episode 12! Join @MAgarwalMD1 and @KrcRebecca  as they dive into the transformative #ABS300in10 2-month fellowship program focusing on advancing #brachy. bit.ly/4a0Lf8Z #ThisIsBrachytherapy #brachytherapy


Hayden Ansinelli 님이 재게시함

Dear @Humana, my patient with oligometastatic prostate cancer (CHAARTED-defined) qualifies for prostate-directed radiotherapy per STAMPEDE Arm H—a Phase III trial showing overall survival benefit. Despite 3D radiotherapy approval, IMRT was denied. I was denied peer-to-peer review…


Hayden Ansinelli 님이 재게시함

Mark your calendar: The 2025 Radiosurgery Society Scientific Meeting will be held March 20-22, 2025 in Tucson, AZ. Look out for registration info in July! #2025RSS

the_RSS's tweet image. Mark your calendar: The 2025 Radiosurgery Society Scientific Meeting will be held March 20-22, 2025 in Tucson, AZ. Look out for registration info in July! #2025RSS

Hayden Ansinelli 님이 재게시함

@evicorehc @AnthemBCBS denying IMRT over 3D for a young breast cancer in a patient < 40 - 3D plan not meeting constraints, plan sent. Denied. Staff told there is NO option for a “peer”-to-peer or reconsideration. !? This should be a no brainer. Do better for my patient @evicorehc


Hayden Ansinelli 님이 재게시함

Sad to see that IMRT is not covered by @UHC @askUHC for limited stage small cell lung cancer, particularly given encouraging findings regarding dose escalation vs. SoC from two Phase II trials, known association of heart dose on survival, and @NCCN recommending IMRT over 3D-CRT.


Hayden Ansinelli 님이 재게시함

it’s always gratifying to see your trainee Phil pifer now extending state of the art kelowna hybrid brachytherapy in the state of West Virginia @bindhu2102 @AndrewKellerMD @AmericanBrachy @KamravaMD @VarianMedSys

Sushilberiwal's tweet image. it’s always gratifying to see your trainee Phil pifer now extending  state of the art kelowna hybrid brachytherapy in the state of West Virginia @bindhu2102 @AndrewKellerMD @AmericanBrachy @KamravaMD @VarianMedSys
Sushilberiwal's tweet image. it’s always gratifying to see your trainee Phil pifer now extending  state of the art kelowna hybrid brachytherapy in the state of West Virginia @bindhu2102 @AndrewKellerMD @AmericanBrachy @KamravaMD @VarianMedSys

Hayden Ansinelli 님이 재게시함

Spent the week with my mom. Radiation and multiple surgeries for a high grade liposarcoma left her unable to sit for the better part of 8 months. Now here she is, sitting and cancer free.

DGlaucomflecken's tweet image. Spent the week with my mom. Radiation and multiple surgeries for a high grade liposarcoma left her unable to sit for the better part of 8 months. Now here she is, sitting and cancer free.

Hayden Ansinelli 님이 재게시함

Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ @IASLC @MDAndersonNews @TheLancet @ACKoongMDPhD @StephenVLiu

JoeChangMD's tweet image. Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.

awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC 
@MDAndersonNews @TheLancet @ACKoongMDPhD 
@StephenVLiu
JoeChangMD's tweet image. Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.

awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC 
@MDAndersonNews @TheLancet @ACKoongMDPhD 
@StephenVLiu

Hayden Ansinelli 님이 재게시함

The great ⁦@Raj_Singh_MD⁩ sharing his study utilizing #SBRT in extracranial sarcoma metastases at #RSS2023@the_RSS@OSUWexMed⁩ ⁦@VCUMassey⁩ ⁦@VCURadOncRes

EricLehrer's tweet image. The great ⁦@Raj_Singh_MD⁩ sharing his study utilizing #SBRT in extracranial sarcoma metastases at #RSS2023 ⁦@the_RSS⁩ @OSUWexMed⁩ ⁦@VCUMassey⁩ ⁦@VCURadOncRes⁩

United States 트렌드

Loading...

Something went wrong.


Something went wrong.